IRTA Pubpro. Open Digital Archive
Publicación
Artículo científico (JournalArticle)
A Protein Misfolding Shaking Amplificationbased method for the spontaneous generation of hundreds of bona fide prions
Prion diseases are a group of rapidly progressing neurodegenerative disorders
caused by the misfolding of the endogenous prion protein (PrPC) into a
pathogenic form (PrPSc). This process, despite being the central event underlying these disorders, remains largely unknown at a molecular level, precluding the prediction of new potential outbreaks or interspecies transmission
incidents. In this work, we present a method to generate bona fide recombinant prions de novo, allowing a comprehensive analysis of protein misfolding
across a wide range of prion proteins from mammalian species. We study more
than 380 different prion proteins from mammals and classify them according
to their spontaneous misfolding propensity and their conformational variability. This study aims to address fundamental questions in the prion research
field such as defining infectivity determinants, interspecies transmission barriers or the structural influence of specific amino acids and provide invaluable
information for future diagnosis and therapy applications., The authors would like to thank the following for their support: IKERBasque foundation, personnel from vivarium, IT service (in particular to Sara Gómez Ramos for her assistance with the PrPdex webpage), maintenance departments of CIC bioGUNE, Neiker and IRTA-CReSA. The authors would also like to acknowledge the work from past laboratory members of the Prion Research Lab from CIC bioGUNE, that despite not directly involved in the manuscript have contributed along the years to the development of all the methods and techniques currently used in the laboratory (specially to Tomás Barrio and Leire Hervá for their efforts at the initial and end stages of the work, respectively). Finally, we would like to thank Jesús R. Requena for always useful scientific discussions and advice. The present work was partially funded by different grants awarded by “Ministerio de Economía y Competitividad” (Spanish Government), grant numbers PID2021-122201OB-C21, PID2021-1222010BC22, PID2021-125946OB-I00 and IJC2020-045506-I, funded by MCIN/ AEI /10.13039/501100011033 and co-financed by the European Regional Development Fund (ERDF), and by the Instituto de Salud Carlos III (ISCIII), grant number AC21_2/00024, to J.C. Additionally, CIC bioGUNE currently holds a Severo Ochoa Excellence accreditation, CEX2021- 001136-S, also funded by MCIN/AEI /10.13039/501100011033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., info:eu-repo/semantics/publishedVersion
Proyecto:
MICINN / Programa Estatal para impulsar la investigación científico-técnica y su transferencia PID2021-122201OB-C21
,
MICINN / Programa Estatal para impulsar la investigación científico-técnica y su transferencia PID2021-122201OB-C22
,
MICINN / Programa Estatal para impulsar la investigación científico-técnica y su transferencia PID2021-125946OB-I00
,
MICINN / Programa Estatal de promoción del talento y su empleabilidad en I+D+I IJC2020-045506-I
,
FEDER / Programa Estatal de generación del conocimiento y fortalecimiento científico y tecnológico del sistema I+D+I AC21_2-00024
,
ISCIII CEX2021-001136-S